Fas ligand derivative

Details Fas ligand derivative Fas ligand derivative

2005-10-04

2005-10-04

Harris, Alana M. (Department: 1642)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C530S300000, C536S001001, C536S018700, C536S022100, C536S023100, C536S023400, C536S023500, C435S007600

Reexamination Certificate

active

06951919

ABSTRACT:
This invention provides a soluble Fas ligand which functions as a Fas antagonist or an apoptosis regulator, a novel Fas ligand derivative which has excellent apoptosis-inducing activity and cytotoxic activity, and a DNA encoding such peptide.

REFERENCES:
patent: 6183951 (2001-02-01), Plevy et al.
patent: 2002/0064869 (2002-05-01), Ebner
patent: 2002/0081647 (2002-06-01), Ebner
patent: 9-124510 (1997-05-01), None
patent: WO9821232 (1998-05-01), None
Hurtenbach et al. Prevention of Autoimmune Diabetes in Non-Obese Diabetic Mice by Treatment with a Class II Major Histocompatibility Complex-blocking Peptide. J. Exp. Med 177:1499-1504, May 1993.
Amino acid database, Accession A49266, Jan. 13, 1995.
Suda et al. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178, Dec. 17, 1993.
Amino acid and nucleic acid database sheets, Sequences 11, 13 and 14 of U.S. Patent No. 6,183,951.
GenCore database sheets. Amino acid comparison between Applicants' Seq Id No.: 17 and prior art, 3 sheets.
Takahashi et al. Human Fas ligand: gene structure, chromosomal location and species specificity. International Immunology 6(10): 1567-1574, 1994.
Mita et al. Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochemical and Biophysical Research Communications 204(2): 468-474, Oct. 28, 1994.
Su et al. Cloning and characterization of gene TNF alpha encoding equine tumor necrosis factor alpha. Gene 107:319-321, 1991.
Weil and Dautry. Induction of Tumor NEcrosis Factore alpha and beta and Interferon gamma mRNA by Interleukin 2 in Murine lymphocytic cell lines. Oncogene Research 3: 409-414, 1988.
Gardner et al. Mouse lymphotoxin and tumor necrosis factor: structural analysis of the cloned genes, physical linkage and chromosomal position. The Journal of Immunology 139(2): 476-483, Jul. 15, 1987.
Gray et al. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tomour necrosis activity. Nature 312 (20/27): 721-724, Dec. 1984.
Tanaka, M. et al., Nature Medicine (1996) vol. 2, No. 3 p. 317-322.
Takahashi, T. et al., International Immunology (1994) vol. 6, No. 10 p-1567-1575.
Tanaka, M. et al., Nature Medicine (1998) vol. 4, No. 5 p-31-36.

Affiliated with

Also associated with

Rating

Fas ligand derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fas ligand derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fas ligand derivative will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3485223